[EXISTENCE OF CHANGES IN HEMOSTASIS WITH DECREASED FIBRINOLYSIS. BASIS FOR THE HEMOSTATIC TREATMENT WITH EPSILON AMINOCAPROIC ACID IN NON FIBRINOLYTIC HEMORRHAGIC DIATHESIS].
D000614:Aminocaproates; D015119:Aminocaproic Acid; D001780:Blood Coagulation Tests; D001791:Blood Platelet Disorders; D001792:Blood Platelets; D003850:Deoxyribonuclease I; D005342:Fibrinolysis; D006474:Hemorrhagic Disorders; D006487:Hemostasis; D006490:Hemostatics; D006801:Humans; D013299:Streptodornase and Streptokinase; D013300:Streptokinase
D000614:Aminocaproates; D006490:Hemostatics; D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I; D013300:Streptokinase; D015119:Aminocaproic Acid
AMINOCAPROIC ACID; BLOOD COAGULATION TESTS; BLOOD PLATELET DISORDERS; BLOOD PLATELETS; FIBRINOLYSIS; HEMORRHAGIC DIATHESIS; STREPTODORNASE AND STREPTOKINASE
EXISTENCIA DE ALTERACIONES DE HEMOSTASIA CON FIBRINOLISIS DISMINUIDA. BASE PARA EL TRATAMIENTO HEMOST'ATICO CON 'ACIDO-EPSILON-AMINOCAPR'OICO EN DIETESIS HEMORR'AGICAS NO FIBRINOL'ITICAS.